1、2025/5/9 09:05S-1/Ahttps:/www.sec.gov/Archives/edgar/data/1673743/000119312525112887/d829170ds1a.htm1/336S-1/A 1 d829170ds1a.htm S-1/ATable of ContentsAs filed with the U.S.Securities and Exchange Commission on May 5,2025.Registration No.333-285682 UNITED STATESSECURITIES AND EXCHANGE COMMISSIONWash

2、ington,D.C.20549 AMENDMENT NO.2TOFORM S-1REGISTRATION STATEMENTUNDERTHE SECURITIES ACT OF 1933 Hinge Health,Inc.(Exact name of registrant as specified in its charter)Delaware 7370 81-1884841(State or other jurisdiction ofincorporation or organization)(Primary Standard IndustrialClassification Code N

3、umber)(I.R.S.EmployerIdentification Number)455 Market Street,Suite 700San Francisco,California 94105(415)726-2206(Address,including zip code,and telephone number,including area code,of registrants principal executive offices)Daniel PerezChief Executive OfficerHinge Health,Inc.455 Market Street,Suite

4、 700San Francisco,California 94105(415)726-2206(Name,address,including zip code,and telephone number,including area code,of agent for service)Copies to:Tad J.FreeseErica D.KassmanLatham&Watkins LLP140 Scott DriveMenlo Park,California 94025(650)328-4600 David WoodHinge Health,Inc.455 Market Street,Su

5、ite 700San Francisco,California 94105(415)726-2206 Alan F.DenenbergShane TintleDavis Polk&Wardwell LLP900 Middlefield Road,Suite 200Redwood City,California 94063(650)752-2000 Approximate date of commencement of proposed sale to the public:As soon as practicable after the effective date of this regis

6、tration statement.If any of the securities being registered on this Form are to be offered on a delayed or continuous basis pursuant to Rule 415 under the Securities Act of 1933,check the followingbox.If this Form is filed to register additional securities for an offering pursuant to Rule 462(b)unde